References
- Rosen MR, Danilo P Jr. The electrophysiological basis for cardiac arrhythmias. In: Narula OS, ed. Cardiac arrhythmias: electrophysiology, diagnosis and management. Baltimore: Williams & Wilkins, 1979: 3
- Zipes DP, Jalife J, eds. Cardiac electrophysiology and arrhythmias. Part 6. Mechanisms of arrhythmia development, II. Orlando, FL: Grune & Stratton, 1985: 325
- Akhtar M, Fisher JD, Gillette PC, et al. Report of the Ad Hoc Committee of the North American Society of Pacing and Electrophysiology on Endocardial Stimulation and Recording Procedures. PACE 1985: 8: 611
- Wu D, Amat-y-Leon F, Simpson RJ Jr, et al. Electrophysiological studies with multiple drugs in patients with atrioventricular re-entrant tachycardias utilizing an extranodal pathway. Circulation 1977: 56(5): 727–36
- Chang MS, Sung RJ, Tal TV, et al. Nadolol and supraventricular tachycardia: an electrophysiologic study. J Am Coll Cardiol 1983: 2(5): 894–903
- Saksena S, Shah Y, Boccadomo R, et al. Intravenous nadolol for refractory supraventricular tachycardia: mechanisms, electropharmacology, efficacy and safety. (Abstr) PACE 1985: 8: 305
- Waxman HL, Myerburg RJ, Appel R, et al. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study. Ann Intern Med 1981: 94(1): 1–6
- Sung RJ, Elser B, McAllister RG Jr. Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations. Ann Intern Med 1980: 93(5): 682–9
- Rozanski J J, Zaman L, Castellanos A. Electrophysiologic effects of diltiazem hydrochloride in supraventricular tachycardia. Am J Cardiol 1982: 49(3): 621–8
- Yeh SJ, Kou HC, Lin FC, et al. Effects of oral diltiazem in paroxysmal supraventricular tachycardia. Am J Cardiol 1983: 52(3): 271–8
- Saksena S, Jacobs J, Rothbart ST. Role of electrophysiologic studies with acute drug testing in refractory supraventricular tachycardia. In: Steinkopff D. Cardiac pacing. New York: Springer-Veriag, 1983: 711–8
- Sealy WC, Anderson RW, Gallagher JJ. Surgical treatment of supraventricular arrhythmias. J Thorac Cardiovasc Surg 1977: 73(4): 511–22
- Scheinman MM, Morady F, Hess DS, et al. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 1982: 248(7): 851–5
- Gallagher JJ, Svenson RH, Kasell JH, et al. Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 1982: 306(4): 194–200
- Spielman SR, Greenspan AM, Kay HR, et al. Electrophysiologic testing in patients at high risk for sudden death. 1. Nonsustained ventricular tachycardia and abnormal ventricular function. J Am Coll Cardiol 1985: 6(l): 31–40
- Waxman HL, Buxton AE, Sadowski LM, et al. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other indications. Circulation 1983: 67(1): 30–7
- Rae AP, Sokoloff NM, Webb CR, et al. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy. J Am Coll Cardiol 1985: 6(2): 410–6
- Horowitz LN, Greenspan AM, Spielman SR, et al. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. Am J Cardiol 1985: 55(4): 367–71
- Lavery D, Saksena S, Gordon S, et al. Long-term efficacy of amiodarone therapy in refractory sustained ventricular tachycardia: the role of electrophysiologic studies and ambulatory monitoring. J Am Coll Cardiol 1986: 91A
- Fisher JD, Kim SG, Furman S, et al. Role of implantable pacemakers in control of recurrent ventricular tachycardia. Am J Cardiol 1982: 49(1): 194–206
- Josephson ME, Harken AH, Horowitz LN. Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia. Circulation 1979: 60(7): 1430–9
- Ferguson D, Saksena S, Greenberg E, et al. Management of recurrent ventricular tachycardia: economic impact of therapeutic alternatives. Am J Cardiol 1984: 53(4): 531–6
- Velebit V, Podrid P. Lown B, et al. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 1982: 65(5): 886–94